ampicillin sulbactam
Selected indexed studies
- Ampicillin-sulbactam against Acinetobacter baumannii infections: pharmacokinetic/pharmacodynamic appraisal of current susceptibility breakpoints and dosing recommendations. (J Antimicrob Chemother, 2024) [PMID:39031073]
- Ampicillin-sulbactam versus third-generation cephalosporins in aspiration Pneumonia: A nationwide retrospective cohort study. (Respir Med, 2025) [PMID:40716681]
- Ampicillin/sulbactam-induced Kounis syndrome with cardiogenic shock. (Anatol J Cardiol, 2017) [PMID:28209929]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ampicillin-sulbactam against Acinetobacter baumannii infections: pharmacokinetic/pharmacodynamic appraisal of current susceptibility breakpoints and dosing recommendations. (2024) pubmed
- Ampicillin-sulbactam versus third-generation cephalosporins in aspiration Pneumonia: A nationwide retrospective cohort study. (2025) pubmed
- Ampicillin/sulbactam-induced Kounis syndrome with cardiogenic shock. (2017) pubmed
- Experience with ampicillin/sulbactam in severe infections. (2002) pubmed
- Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections. (2009) pubmed
- Ampicillin-sulbactam. (1993) pubmed
- Ampicillin/sulbactam: its potential use in treating infections in critically ill patients. (2013) pubmed
- Ampicillin/sulbactam (Unasyn). (1987) pubmed
- Ampicillin-sulbactam monotherapy in infants with febrile urinary tract infections. (2021) pubmed
- Effect of Clindamycin compared with Ampicillin-Sulbactam as prophylactic antibiotics for wound infections following major surgery for head and neck cancer: A meta-analysis. (2023) pubmed